Adaptimmune Therapeutics PLC Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptimmune Therapeutics PLC for June 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 26 2018 | ADAP | Adaptimmune Therap ... | MOTT DAVID M | Director | Option Exercise | A | 2.18 | 187,330 | 408,379 | 187,330 | |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Option Exercise | A | 2.18 | 154,809 | 337,484 | 154,809 | |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Kerr Giles Francis Bertram | Director | Option Exercise | A | 2.18 | 124,000 | 270,320 | 124,000 | |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Alleva Lawrence M | Director | Option Exercise | A | 2.18 | 124,000 | 270,320 | 124,000 | |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Zaks Tal Zvi | Director | Option Exercise | A | 2.18 | 124,000 | 270,320 | 124,000 | |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Duncan Barbara Gayle | Director | Option Exercise | A | 2.18 | 158,233 | 344,948 | 158,233 | |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Option Exercise | A | 2.18 | 154,809 | 337,484 | 154,809 | |
Jun 06 2018 | ADAP | Adaptimmune Therap ... | Thompson Peter A. | Director | Sell | S | 13.49 | 1,600 | 21,584 | 4,901,310 | 4.9 M to 4.9 M (-0.03 %) |
Jun 06 2018 | ADAP | Adaptimmune Therap ... | Thompson Peter A. | Director | Sell | S | 13.57 | 17,100 | 232,047 | 4,902,910 | 4.9 M to 4.9 M (-0.35 %) |
Jun 06 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.49 | 1,600 | 21,584 | 4,901,310 | 4.9 M to 4.9 M (-0.03 %) |
Jun 06 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.57 | 17,100 | 232,047 | 4,902,910 | 4.9 M to 4.9 M (-0.35 %) |
Jun 01 2018 | ADAP | Adaptimmune Therap ... | Thompson Peter A. | Director | Sell | S | 13.49 | 50,000 | 674,500 | 4,920,010 | 5 M to 4.9 M (-1.01 %) |
Jun 01 2018 | ADAP | Adaptimmune Therap ... | Thompson Peter A. | Director | Sell | S | 13.52 | 121,000 | 1,635,920 | 4,970,010 | 5.1 M to 5 M (-2.38 %) |
Jun 01 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.49 | 50,000 | 674,500 | 4,920,010 | 5 M to 4.9 M (-1.01 %) |
Jun 01 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.52 | 121,000 | 1,635,920 | 4,970,010 | 5.1 M to 5 M (-2.38 %) |